These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2749748)

  • 1. Formation of nuclear anomalies in rat intestine by benzidine and its biliary metabolites.
    Percy AJ; Moore N; Chipman JK
    Toxicology; 1989 Jul; 57(2):217-23. PubMed ID: 2749748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites.
    Lynn RK; Garvie-Gould CT; Milam DF; Scott KF; Eastman CL; Ilias AM; Rodgers RM
    Toxicol Appl Pharmacol; 1984 Jan; 72(1):1-14. PubMed ID: 6710475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-mediated bacterial mutagenesis and enterohepatic circulation of benzidine-derived mutagenic metabolites in rodents.
    Chipman JK; Mohn GR
    Xenobiotica; 1989 Jan; 19(1):43-50. PubMed ID: 2667260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the human carcinogen, benzidine, in the isolated perfused rat liver.
    Lynn RK; Garvie-Gould C; Milam DF; Scott KF; Eastman CL; Rodgers RM
    Drug Metab Dispos; 1983; 11(2):109-14. PubMed ID: 6133713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolic activation of benzidine by isolated rat hepatocytes.
    Brouns RM; Bos RP; Van Doorn R; Henderson PT
    Toxicology; 1982; 23(2-3):235-47. PubMed ID: 7112596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific modulation of carcinogen-induced gastrointestinal tract nuclear anomalies in B6C3F1 mice by chloroform.
    Daniel FB; Reddy TV; Stober JA; Olson GR
    Anticancer Res; 1991; 11(2):665-70. PubMed ID: 2064320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vivo assay for small intestine genotoxicity.
    Goldberg MT; Chidiac P
    Mutat Res; 1986 Aug; 164(4):209-15. PubMed ID: 3748059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of urothelial tumors in the heterotopic bladder of rat by benzidine derivatives.
    Wang CY; Zukowski K; Yamada H; Imaida K; Lee MS
    Cancer Res; 1990 May; 50(10):2868-71. PubMed ID: 2110501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric and kinetic studies on the changes induced in the intestinal mucosa of rats by intraperitoneal administration of quinacrine.
    Senior PV; Sunter JP; Appleton DR; Watson AJ
    Cell Tissue Kinet; 1984 Sep; 17(5):445-52. PubMed ID: 6467329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 1,2-dimethylhydrazine-induced nuclear damage in rat colonic epithelium by chlorophyllin.
    Robins EW; Nelson RL
    Anticancer Res; 1989; 9(4):981-5. PubMed ID: 2817825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of azo dyes derived from benzidine, 3,3'-dimethyl-benzidine and 3,3'-dimethoxybenzidine to potentially carcinogenic aromatic amines by intestinal bacteria.
    Cerniglia CE; Freeman JP; Franklin W; Pack LD
    Carcinogenesis; 1982; 3(11):1255-60. PubMed ID: 7151244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine.
    Frederick CB; Weis CC; Flammang TJ; Martin CN; Kadlubar FF
    Carcinogenesis; 1985 Jul; 6(7):959-65. PubMed ID: 4017176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological acetylation of a benzidine in Sprague-Dawley rat].
    Laham S; Dulos E; Chang W
    Biomedicine; 1974 Jul; 21(7):299-302. PubMed ID: 4433663
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism, distribution, and excretion of the carcinogenic aromatic amine, 3,3'-dimethoxybenzidine in the rat. Formation of mutagenic urinary and biliary metabolites.
    Rodgers RM; Garvie-Gould C; Scott KF; Milam DF; Lynn RK
    Drug Metab Dispos; 1983; 11(4):293-300. PubMed ID: 6137333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity of benzidine, N,N'-diacetylbenzidine, and N-hydroxy-N,N'-diacetylbenzidine for female CD rats.
    Morton KC; Wang CY; Garner CD; Shirai T
    Carcinogenesis; 1981; 2(8):747-52. PubMed ID: 7285281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effects of benzidine in mice: evidence of alterations in arachidonic acid metabolism.
    Luster MI; Tucker AN; Hayes HT; Pung OJ; Burka T; McMillan R; Eling T
    J Immunol; 1985 Oct; 135(4):2754-61. PubMed ID: 2993415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of acetyl-CoA supplementation on the mutagenicity of benzidines in the Ames assay.
    Kennelly JC; Stanton CA; Martin CN
    Mutat Res; 1984 Jul; 137(1):39-45. PubMed ID: 6379437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internal exposure of rats to benzidine derived from orally administered benzidine-based dyes after intestinal azo reduction.
    Bos RP; van der Krieken W; Smeijsters L; Koopman JP; de Jonge HR; Theuws JL; Henderson PT
    Toxicology; 1986 Aug; 40(2):207-13. PubMed ID: 3726894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzidine activation in the Ames test: roles of hepatic N-acetyltransferase and other cytosolic and microsomal factors.
    Light HC; Hubert JJ; Josephy PD; Mattano SS; Weber WW
    Carcinogenesis; 1987 Jan; 8(1):139-43. PubMed ID: 3542272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers.
    Rothman N; Bhatnagar VK; Hayes RB; Zenser TV; Kashyap SK; Butler MA; Bell DA; Lakshmi V; Jaeger M; Kashyap R; Hirvonen A; Schulte PA; Dosemeci M; Hsu F; Parikh DJ; Davis BB; Talaska G
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5084-9. PubMed ID: 8643532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.